Medidata Medidata


A Statement from our Co-Founders and Co-CEOs Glen de Vries and Tarek Sherif

Your Research Brings Hope To Millions of Patients. Our Platform Accelerates it.

Acorn AI is designed to make data liquid across the lifecycle and answer the most important questions.

The Impact of COVID-19 on Clinical Trial Sites

Medidata surveyed over 1,000 sites to see how the COVID-19 pandemic is affecting their ability to start, conduct and complete clinical studies.

Stay informed: Medidata’s customer commitment during COVID-19 (Learn more)

COVID:19 and Clinical Trials: The Medidata Perspective

Release 5.0

As the global impact of COVID-19 increases, Medidata is continuously analyzing its effect on patient study enrollment, the response by world regulatory bodies and which Medidata’s solutions can help address your COVID 19-related challenges.

Dr. Miganush Stepanians
President and CEO, PROMETRIKA
Rave EDC, Rave RTSM and Rave eCOA/ePRO

See for yourself why life science companies big and small trust the Medidata platform.

Help Us Power Technology That Changes Lives